Gastrointestinal Cancers Symposium Media Resource Center.

Embargo Policy

The embargo on all abstracts part of the 2015 Gastrointestinal Cancers Symposium will lift at 5:00 PM ET on Monday, January 12, 2015. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 12 for credentialed media.

How to Obtain Media Credentials and/or Register to Attend the Symposium in San Francisco

Media registration for the 2015 Gastrointestinal Cancers Symposium will open on November 6, 2014.

ASCO's Media Headquarters is where you can apply for media credentials*, register to attend an upcoming meeting, and access embargoed meeting information. For questions about how to navigate the site, please contact mediaregistration@asco.org

*If you attended the 2014 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the January 12 Presscast. You only have to register if you would like to attend the Symposium in San Francisco.

2015 Gastrointestinal Symposium Media Registration and Housing Instructions

Please refer to the 2015 Gastrointestinal Cancers Symposium Media Policies for eligibility information.

Access Embargoed Information

Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.

View the January 12 Press Briefing

The January 12 press briefing recording is available in ASCO's Video Gallery.

Press Releases

Symposium to Feature New Research Advances in Gastrointestinal Cancers
 
SAN FRANCISCO – Four abstracts with significant insight for the screening and treatment of gastrointestinal cancers will be presented at the 2015 Gastrointestinal Cancers Symposium, taking place January 15-17 in San Francisco. Read the rull release.

Surgery May Not Be Necessary for Some Patients With Rectal Cancer – Chemoradiation Plus “Watch and Wait” Appears Safe, May Offer Better Quality of Life
ALEXANDRIA, Va. – A retrospective review of clinical data on 145 patients with stage I-III rectal cancer indicates that patients whose tumors completely disappeared after treatment with chemoradiation and systemic chemotherapy (known as a complete response) had similar four-year survival rates regardless of whether they had immediate surgery or pursued a “watch and wait” surveillance approach. Read the full release.

Second-Line Ramucirumab Added to Standard Chemotherapy Delays Disease Progression, Extends Survival for Patients With Advanced Colorectal Cancer
ALEXANDRIA, Va. – New findings from an international phase III study of 1,072 patients with advanced colorectal cancer whose disease progressed on or after initial therapy indicate that a combination of the targeted drug ramucirumab and FOLFIRI chemotherapy provides a survival advantage over standard treatment with FOLFIRI alone. Read the full release.

Combining Newer, More Intensive First-Line Chemotherapy With Bevacizumab Improves Long-Term Outcome in Advanced Colorectal Cancer
ALEXANDRIA, Va. – Updated results from TRIBE, an Italian phase III study of patients with metastatic colorectal cancer, indicate that FOLFOXIRI chemotherapy in combination with bevacizumab is superior to the standard FOLFIRI chemotherapy with bevacizumab. Read the full release.

Higher Vitamin D Levels Associated With Markedly Improved Survival in Patients With Advanced Colorectal Cancer
ALEXANDRIA, Va. – A prospective analysis of data from a phase III study of patients newly diagnosed with metastatic colorectal cancer indicates that patients with higher vitamin D levels have better outcomes after treatment with chemotherapy and targeted therapy. Read the full release.

2015 Gastrointestinal Cancers Symposium Press Program to Highlight Treatment and Management of Colorectal and Rectal Cancers
ALEXANDRIA, Va. – Co-sponsors announced today four studies to be featured in the 2015 Gastrointestinal Cancers Symposium press program. Researchers will present the study findings in an embargoed presscast for reporters on Monday, January 12, 2015, from 12:00-1:30 PM (EST). Read the full release.

On-Site Information

Information About the On-Site Press Facilities (including location and hours)

Meeting Information

Meet the News Planning Team

Smitha S. Krishnamurthi, MD
American Society of Clinical Oncology (ASCO)
Case Western Reserve University

William M. Grady, MD
American Gastroenterological Association (AGA) Institute
Fred Hutchinson Cancer Research Center

Joel E. Tepper, MD
American Society for Radiation Oncology (ASTRO)
University of North Carolina School of Medicine

Nipun B. Merchant, MD
Society of Surgical Oncology (SSO) 
University of Miami Medical Center

Media Resources

How Can We Help You?

Interview Requests
mediateam@asco.org
Please do not send media registration requests to this email address.

Media Registration Questions
mediaregistration@asco.org

General Questions About the Meeting
Kelly Baldwin, kelly.baldwin@asco.org
Kate Blackburn, kate.blackburn@asco.org
Alise Fisher, alise.fisher@asco.org